Table 2.

Patient demographics

Patient characteristicsPatients (N = 62), n (%)
Age, years
 Median58
 Range33–81
Performance status
 022 (35)
 140 (65)
Male/females26/36 (42/58)
Patients with prior chemotherapy62
Median number of prior chemotherapy regimens3
 Range1–10
Tumor typesTotal
 Non–small cell lung19 (31)
  KRAS mutant13 (21)
 Colorectal14 (23)
  KRAS mutant9 (15)
 Ovarian5 (8)
  KRAS mutant2 (3)
 Pancreatic5 (8)
  KRAS mutant4 (6)
 Breast3 (5)
 Leiomyosarcoma3 (5)
 Ewing sarcoma2 (3)
 Prostate2 (3)
 Melanoma2 (3)
 Appendix, cervical (squamous), chondrosarcoma, esophageal, liver, Merkel cell, thyroid7 total [1 each](11 [2])
  KRAS mutant1 (2)